• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.00
+0 (0.00%)
Get New NewAge Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NBEV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NBEV

Analyst Price Target is $0.00
This price target is based on 0 analysts offering 12 month price targets for NewAge in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.

This chart shows the closing price for NBEV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in NewAge. This rating has held steady since August 2023, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
8/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/16/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/15/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/14/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/31/2022Alliance Global PartnersDowngradeBuy ➝ Sell
8/10/2021Alliance Global PartnersReiterated RatingBuy
8/10/2021Roth CapitalLower TargetBuy$6.50 ➝ $6.00
8/4/2021Roth CapitalReiterated RatingBuy
7/22/2020Northland SecuritiesInitiated CoverageHold
7/21/2020Alliance Global PartnersBoost Target$3.50 ➝ $5.00
4/17/2020Northland SecuritiesReiterated RatingHold
3/11/2020Compass PointLower Target$9.00 ➝ $4.00
(Data available from 2/14/2020 forward)

News Sentiment Rating

1.35 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/19/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/18/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/17/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/17/2024
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/15/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/14/2025

Current Sentiment

  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
NewAge logo
NewAge, Inc. develops, markets, sells, and distributes healthy products in the United States, Japan, China, and internationally. The company operates in two segments, Direct / Social Selling and Direct Store. It provides health and wellness, energy drink, essential oil and anti-aging skincare, cosmetic, beverage, snacks, water and air filtration, and personal care products, as well as weight management, nutritional supplement, nutraceutical, and slenderiize products; diagnostic products, such as DNA testing and diagnostic kits and products; and CBD products. The company offers its products under the Tahitian Noni, LIMU, Zennoa, LIMU Blue Frog, Hiro Natural, TeMana, Lucim, Reviive, Puritii, and MaVie brands. It sells its products directly to customers, as well as through distributors, e-commerce sites, and direct-store-delivery systems. The company was formerly known as New Age Beverages Corporation and changed its name to NewAge, Inc. in July 2020. NewAge, Inc. was incorporated in 2010 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.23
Low: $0.09
High: $0.36

52 Week Range

Now: N/A

Volume

2,575,326 shs

Average Volume

4,663,287 shs

Market Capitalization

$12.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.55

Frequently Asked Questions

What sell-side analysts currently cover shares of NewAge?

The following Wall Street sell-side analysts have issued reports on NewAge in the last year:
View the latest analyst ratings for NBEV.

What is the current price target for NewAge?

0 Wall Street analysts have set twelve-month price targets for NewAge in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for NewAge in the next year.
View the latest price targets for NBEV.

What is the current consensus analyst rating for NewAge?

NewAge currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NBEV.

What other companies compete with NewAge?

How do I contact NewAge's investor relations team?

NewAge's physical mailing address is 2420 17TH STREET SUITE 220, DENVER CO, 80202. The company's listed phone number is (303) 566-3030 and its investor relations email address is [email protected]. The official website for NewAge is newagebev.us. Learn More about contacing NewAge investor relations.